Figures & data
Figure 1. The process of data inclusion and grouping. AP: acute pancreatitis; HTG-AP: hypertriglyceridemic acute pancreatitis; SAP: severe acute pancreatitis; MSAP: moderately severe acute pancreatitis; MAP: mild acute pancreatitis; LMWH: low molecular weight heparin; BISAP: bedside index for severity in acute pancreatitis.
![Figure 1. The process of data inclusion and grouping. AP: acute pancreatitis; HTG-AP: hypertriglyceridemic acute pancreatitis; SAP: severe acute pancreatitis; MSAP: moderately severe acute pancreatitis; MAP: mild acute pancreatitis; LMWH: low molecular weight heparin; BISAP: bedside index for severity in acute pancreatitis.](/cms/asset/8d537c66-1741-4aa3-bea6-a8a3533c29bb/igas_a_2342406_f0001_b.jpg)
Figure 2. The number of patients with HTG-AP and other AP in the Civil Aviation General Hospital from January 2012 to December 2023. AP: acute pancreatitis; HTG-AP: hypertriglyceridemic acute pancreatitis.
![Figure 2. The number of patients with HTG-AP and other AP in the Civil Aviation General Hospital from January 2012 to December 2023. AP: acute pancreatitis; HTG-AP: hypertriglyceridemic acute pancreatitis.](/cms/asset/c8e59839-6673-4900-abf0-0adba739d9d5/igas_a_2342406_f0002_c.jpg)
Table 1. The general clinical data of MAP,MSAP and SAP.
Table 2. Characteristics and clinical outcomes of 48-h and 72-h TG attainment.
Table 3. The area under the ROC curve of TG predicting SAP.
Table 4. Characteristics and clinical outcomes of different lipid-lowering methods.
Table 5. Characteristics and clinical outcomes of different lipid-lowering methods by propensity score matching.